Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,022.95
(
0.80%
)
US TECH 100
25,535.20
(
1.56%
)
Dow Jones
48,463.72
(
-0.15%
)
Brent Oil
92.60
(
-0.07%
)
Bitcoin
75,045.48
(
0.29%
)
News Focus
News Focus
Post# of 517313
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 147
Posts 26175
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: Investor2014 post# 485261

Sunday, 03/23/2025 2:12:39 PM

Sunday, March 23, 2025 2:12:39 PM

Post# of 517313
I do believe that the ADL endpoint achieved statistical significance during the OLE study, since all of the people in the OLE study received a target dose of 50 mg/day of.blarcamesine compared to only 33% of those from the Phase 2/3 trial. And they were farther along in their Alzheimer’s progression.

GOD bless,
Bullish
Bullish
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News